Industrialization trial of a biosensor technology

研究成果: Conference contribution

2 引用 (Scopus)

抄録

A biosensing system is commercialized based on a concept of physiological balance for healthcare. The addition of low-cost biochemical sensors to the sensing system would help with scientific prescriptions based on contemporary medicine. As a candidate for a low-cost and robust chemical sensor platform, the ion-sensitive field-effect transistor (ISFET) has long been examined. After reviewing past ISFET research, our two approaches for new business trials are discussed. One approach is based on the progressiveness of technology that relies on a public finance with existing big companies. Another approach is a lean startup based on a customer development model for entrepreneurs.

元の言語English
ホスト出版物のタイトルContemporary Issues and Case Studies in Electrochemical Innovation 2
出版者Electrochemical Society Inc.
ページ1-9
ページ数9
75
エディション39
ISBN(電子版)9781607685395
DOI
出版物ステータスPublished - 2016 1 1
イベントSymposium on Contemporary Issues and Case Studies in Electrochemical Innovation 2 - PRiME 2016/230th ECS Meeting - Honolulu, United States
継続期間: 2016 10 22016 10 7

Other

OtherSymposium on Contemporary Issues and Case Studies in Electrochemical Innovation 2 - PRiME 2016/230th ECS Meeting
United States
Honolulu
期間16/10/216/10/7

Fingerprint

Ion sensitive field effect transistors
Biosensors
Finance
Chemical sensors
Medicine
Costs
Industry
Sensors

ASJC Scopus subject areas

  • Engineering(all)

これを引用

Ohashi, K., & Osaka, T. (2016). Industrialization trial of a biosensor technology. : Contemporary Issues and Case Studies in Electrochemical Innovation 2 (39 版, 巻 75, pp. 1-9). Electrochemical Society Inc.. https://doi.org/10.1149/07539.0001ecst

Industrialization trial of a biosensor technology. / Ohashi, Keishi; Osaka, Tetsuya.

Contemporary Issues and Case Studies in Electrochemical Innovation 2. 巻 75 39. 編 Electrochemical Society Inc., 2016. p. 1-9.

研究成果: Conference contribution

Ohashi, K & Osaka, T 2016, Industrialization trial of a biosensor technology. : Contemporary Issues and Case Studies in Electrochemical Innovation 2. 39 Edn, 巻. 75, Electrochemical Society Inc., pp. 1-9, Symposium on Contemporary Issues and Case Studies in Electrochemical Innovation 2 - PRiME 2016/230th ECS Meeting, Honolulu, United States, 16/10/2. https://doi.org/10.1149/07539.0001ecst
Ohashi K, Osaka T. Industrialization trial of a biosensor technology. : Contemporary Issues and Case Studies in Electrochemical Innovation 2. 39 版 巻 75. Electrochemical Society Inc. 2016. p. 1-9 https://doi.org/10.1149/07539.0001ecst
Ohashi, Keishi ; Osaka, Tetsuya. / Industrialization trial of a biosensor technology. Contemporary Issues and Case Studies in Electrochemical Innovation 2. 巻 75 39. 版 Electrochemical Society Inc., 2016. pp. 1-9
@inproceedings{0e5a7f0fa4a247eb90cc476d5bd7f9c2,
title = "Industrialization trial of a biosensor technology",
abstract = "A biosensing system is commercialized based on a concept of physiological balance for healthcare. The addition of low-cost biochemical sensors to the sensing system would help with scientific prescriptions based on contemporary medicine. As a candidate for a low-cost and robust chemical sensor platform, the ion-sensitive field-effect transistor (ISFET) has long been examined. After reviewing past ISFET research, our two approaches for new business trials are discussed. One approach is based on the progressiveness of technology that relies on a public finance with existing big companies. Another approach is a lean startup based on a customer development model for entrepreneurs.",
author = "Keishi Ohashi and Tetsuya Osaka",
year = "2016",
month = "1",
day = "1",
doi = "10.1149/07539.0001ecst",
language = "English",
volume = "75",
pages = "1--9",
booktitle = "Contemporary Issues and Case Studies in Electrochemical Innovation 2",
publisher = "Electrochemical Society Inc.",
edition = "39",

}

TY - GEN

T1 - Industrialization trial of a biosensor technology

AU - Ohashi, Keishi

AU - Osaka, Tetsuya

PY - 2016/1/1

Y1 - 2016/1/1

N2 - A biosensing system is commercialized based on a concept of physiological balance for healthcare. The addition of low-cost biochemical sensors to the sensing system would help with scientific prescriptions based on contemporary medicine. As a candidate for a low-cost and robust chemical sensor platform, the ion-sensitive field-effect transistor (ISFET) has long been examined. After reviewing past ISFET research, our two approaches for new business trials are discussed. One approach is based on the progressiveness of technology that relies on a public finance with existing big companies. Another approach is a lean startup based on a customer development model for entrepreneurs.

AB - A biosensing system is commercialized based on a concept of physiological balance for healthcare. The addition of low-cost biochemical sensors to the sensing system would help with scientific prescriptions based on contemporary medicine. As a candidate for a low-cost and robust chemical sensor platform, the ion-sensitive field-effect transistor (ISFET) has long been examined. After reviewing past ISFET research, our two approaches for new business trials are discussed. One approach is based on the progressiveness of technology that relies on a public finance with existing big companies. Another approach is a lean startup based on a customer development model for entrepreneurs.

UR - http://www.scopus.com/inward/record.url?scp=85025130332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025130332&partnerID=8YFLogxK

U2 - 10.1149/07539.0001ecst

DO - 10.1149/07539.0001ecst

M3 - Conference contribution

AN - SCOPUS:85025130332

VL - 75

SP - 1

EP - 9

BT - Contemporary Issues and Case Studies in Electrochemical Innovation 2

PB - Electrochemical Society Inc.

ER -